馬匹保健市場規模、佔有率和成長分析：按產品類型、疾病類型、分銷管道和地區分類－2026-2033年產業預測

2024 年全球馬匹保健市場價值為 40.6 億美元，預計到 2025 年將成長至 43.4 億美元，到 2033 年將成長至 74.6 億美元，在預測期（2026-2033 年）內複合年成長率為 7.0%。

全球馬匹醫療保健市場正經歷顯著成長，這主要得益於多種因素，包括研發活動的活性化、馬匹健康問題的增多以及馬匹療法的日益普及。隨著獸醫研究人員致力於探索創新方法以應對長期存在的挑戰，人工智慧（AI）在馬匹醫療保健領域的應用正顯著推動市場動態。這項技術進步透過促進定期健康評估，提升了馬匹醫療保健管理水平，從而能夠更準確地早期診斷疾病，並提供更廣泛的個人化治療方法方案。全面的馬匹醫療保健涵蓋預防保健、疾病管理、跛行治療、生殖健康、口腔衛生、復健和行為問題管理，最終有助於提高馬匹的整體健康狀況，降低患病風險，並延長其壽命。

全球馬匹保健市場的成長要素

全球馬匹保健市場的主要促進因素之一是馬主和飼養員對動物健康和福利意識的不斷提高。隨著預防保健護理（例如疫苗接種、定期體檢和營養支持）的重要性日益凸顯，馬匹保健服務和產品的支出也不斷成長。此外，馬術比賽和休閒騎乘活動的日益普及也推動了對專業獸醫服務和先進治療方法的需求。這是因為馬主們都希望保持馬匹的最佳健康和競技狀態。這種對負責任的馬匹護理日益成長的興趣正在積極影響市場動態。

全球馬匹醫療保健市場的限制因素

全球馬匹醫療保健市場的主要限制因素之一是獸醫護理和治療的高成本。馬匹醫療保健通常需要專用設備、先進的診斷技術和個人化治療方案，這可能會給馬主帶來沉重的經濟負擔。這種經濟負擔可能會阻礙潛在客戶獲得必要的獸醫服務或投資預防性護理，尤其是在資源匱乏的地區。此外，將馬匹護理視為「奢侈品」而非「必需品」的傾向也會限制市場成長。許多馬主可能會優先考慮馬匹的基本需求而非專業的醫療保健，最終阻礙市場的整體擴張。

全球馬匹保健市場趨勢

全球馬匹醫療保健市場正經歷遠端醫療的重大發展趨勢，徹底改變了獸醫服務的提供方式。數位化平台使獸醫能夠進行遠距會診、監測馬匹復健情況並提供專家指導，從而改善了醫療服務的可及性，尤其是在醫療資源匱乏的農村和醫療服務不足地區。這種創新方法不僅擴大了醫療保健的覆蓋範圍，還降低了運送馬匹進行常規檢查和小型治療所帶來的後勤挑戰和成本。隨著遠端醫療的不斷普及，預計它將在提高獸醫工作效率的同時，改善馬匹的整體健康。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球馬匹保健市場規模：依產品類型分類

• 製藥
• 疫苗
• 醫用飼料添加劑

全球馬匹保健市場規模：依疾病類型分類

• 馬流感
• 馬皰疹病毒
• 馬腦脊髓炎
• 西尼羅河病毒
• 其他

全球馬匹保健市場規模：按分銷管道分類

• 動物醫院
• 動物診所
• 零售藥房
• 網路藥房

全球馬匹保健市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Zoetis Inc.
• Merck Animal Health
• Boehringer Ingelheim International GmbH
• Elanco Animal Health
• Bayer AG
• Ceva Sante Animale
• Virbac
• Dechra Pharmaceuticals PLC
• IDEXX Laboratories, Inc.
• Vetoquinol SA
• Norbrook Laboratories Limited
• EQUINE PRODUCTS UK LTD
• KRKA
• HIPRA
• Luitpold Pharmaceuticals, Inc.
• Sanofi
• Novartis Animal Health
• Animal Health International
• Argenta
• Vetmedin

結論與建議

Global Equine Healthcare Market size was valued at USD 4.06 Billion in 2024 and is poised to grow from USD 4.34 Billion in 2025 to USD 7.46 Billion by 2033, growing at a CAGR of 7.0% during the forecast period (2026-2033).

The global equine healthcare market is experiencing substantial growth due to various factors, including heightened research and development initiatives, a rise in equine health issues, and the growing popularity of equine-based therapies. The integration of artificial intelligence in equine health care is significantly advancing market dynamics, as veterinary researchers focus on innovative practices that address persistent challenges. This technological advancement enhances equine healthcare management by facilitating regular health assessments, leading to improved accuracy in early disease diagnosis and personalized treatment options. Comprehensive equine healthcare encompasses preventive care, illness management, lameness treatment, reproductive health, oral hygiene, rehabilitation, and behavioral issue management, ultimately contributing to better overall health, reduced disease risk, and prolonged lifespans for horses.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Equine Healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Equine Healthcare Market Segments Analysis

Global Equine Healthcare Market is segmented by Product Type, Disease Type, Distribution Channel and region. Based on Product Type, the market is segmented into Drugs, Vaccines and Medical Feed Additives. Based on Disease Type, the market is segmented into Equine Influenza, Equine Herpesvirus, Equine Encephalomyelitis, Equine West Nile Virus and Others. Based on Distribution Channel, the market is segmented into Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Equine Healthcare Market

One of the key market drivers for the global equine healthcare market is the increasing awareness of animal health and welfare among horse owners and caretakers. As people continue to recognize the importance of preventive care, including vaccinations, regular check-ups, and nutritional support, spending on equine healthcare services and products is on the rise. Moreover, the growing participation in equestrian sports and recreational riding contributes to the demand for specialized veterinary services and advanced medical treatments, as owners seek to maintain optimal health and performance of their horses. This heightened focus on responsible ownership is shaping the market dynamics positively.

Restraints in the Global Equine Healthcare Market

One key market restraint for the global equine healthcare market is the high cost of veterinary care and treatments. Equine healthcare often requires specialized equipment, advanced diagnostics, and tailored therapies, which can lead to significant expenses for horse owners. This financial burden may deter potential clients from seeking necessary veterinary services or investing in preventive care, especially in regions with limited resources. Furthermore, the perception of equine care as a luxury rather than a necessity can restrict market growth, as many owners may prioritize basic needs over specialized healthcare for their horses, ultimately hampering the expansion of the overall market.

Market Trends of the Global Equine Healthcare Market

The Global Equine Healthcare market is witnessing a significant trend with the incorporation of telemedicine, revolutionizing how veterinary care is delivered. Digital platforms are enabling veterinarians to conduct remote consultations, monitor equine recovery, and offer expert guidance, thereby enhancing accessibility, especially in rural or underserved areas where advanced veterinary services are scarce. This innovative approach not only broadens access to care but also reduces logistical challenges and costs associated with transporting horses for routine check-ups and minor treatments. As telemedicine continues to gain traction, it is expected to improve overall equine health outcomes while streamlining veterinary operations.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Equine Healthcare Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Drugs
• Vaccines
• Medical Feed Additives

Global Equine Healthcare Market Size by Disease Type & CAGR (2026-2033)

• Market Overview
• Equine Influenza
• Equine Herpesvirus
• Equine Encephalomyelitis
• Equine West Nile Virus
• Others

Global Equine Healthcare Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals
• Veterinary Clinics
• Retail Pharmacies
• Online Pharmacies

Global Equine Healthcare Market Size & CAGR (2026-2033)

• North America (Product Type, Disease Type, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Disease Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Disease Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Disease Type, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Disease Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norbrook Laboratories Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EQUINE PRODUCTS UK LTD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KRKA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HIPRA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luitpold Pharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Animal Health International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Argenta
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetmedin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations